Literature DB >> 18418540

Single-channel characterization of the rabbit recombinant RyR2 reveals a novel inactivation property of physiological concentrations of ATP.

Richard Stewart1, Lele Song, Simon M Carter, Charalambos Sigalas, Nathan R Zaccai, Venkateswarlu Kanamarlapudi, Manjunatha B Bhat, Hiroshi Takeshima, Rebecca Sitsapesan.   

Abstract

Ryanodine receptor 2 (RyR2) cDNA has been available for more than 15 years; however, due to the complex nature of ligand gating in this channel, many aspects of recombinant RyR2 function have been unresearched. We established a stable, inducible HEK 293 cell line expressing full-length rabbit RyR2 cDNA and assessed the single-channel properties of the recombinant RyR2, with particular reference to ligand regulation with Ca2+ as the permeant ion. We found that the single-channel conductances of recombinant RyR2 and RyR2 isolated from cardiac muscle are essentially identical, as is irreversible modification by ryanodine. Although it is known that RyR2 expressed in HEK 293 cells is not associated with FKBP12.6, we demonstrate that these channels do not exhibit any discernable disorganized gating characteristics or subconductance states. We also show that the gating of recombinant RyR2 is indistinguishable from that of channels isolated from cardiac muscle when activated by cytosolic Ca2+, caffeine or suramin. The mechanisms underlying ATP activation are also similar; however, the experiments highlighted a novel effect of ATP at physiologically relevant concentrations of 5-10 mM. With Ca2+ as permeant ion, 5-10 mM ATP consistently inactivated recombinant channels (15/16 experiments). Such inactivation was rarely observed with native RyR2 isolated from cardiac muscle (1 in 16 experiments). However, if the channels were purified, inactivation by ATP was then revealed in all experiments. This action of ATP may be relevant for inactivation of sarcoplasmic reticulum Ca2+ release during cardiac excitation-contraction coupling or may represent unnatural behavior that is revealed when RyR2 is purified or expressed in noncardiac systems.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18418540     DOI: 10.1007/s00232-008-9102-z

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  50 in total

1.  PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.

Authors:  S O Marx; S Reiken; Y Hisamatsu; T Jayaraman; D Burkhoff; N Rosemblit; A R Marks
Journal:  Cell       Date:  2000-05-12       Impact factor: 41.582

2.  Characterization of recombinant skeletal muscle (Ser-2843) and cardiac muscle (Ser-2809) ryanodine receptor phosphorylation mutants.

Authors:  Mirko Stange; Le Xu; David Balshaw; Naohiro Yamaguchi; Gerhard Meissner
Journal:  J Biol Chem       Date:  2003-10-07       Impact factor: 5.157

3.  Characterization of a novel PKA phosphorylation site, serine-2030, reveals no PKA hyperphosphorylation of the cardiac ryanodine receptor in canine heart failure.

Authors:  Bailong Xiao; Ming Tao Jiang; Mingcai Zhao; Dongmei Yang; Cindy Sutherland; F Anthony Lai; Michael P Walsh; David C Warltier; Heping Cheng; S R Wayne Chen
Journal:  Circ Res       Date:  2005-03-24       Impact factor: 17.367

4.  Heterogeneity of Ca2+ gating of skeletal muscle and cardiac ryanodine receptors.

Authors:  J A Copello; S Barg; H Onoue; S Fleischer
Journal:  Biophys J       Date:  1997-07       Impact factor: 4.033

5.  Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia.

Authors:  Björn C Knollmann; Nagesh Chopra; Thinn Hlaing; Brandy Akin; Tao Yang; Kristen Ettensohn; Barbara E C Knollmann; Kenneth D Horton; Neil J Weissman; Izabela Holinstat; Wei Zhang; Dan M Roden; Larry R Jones; Clara Franzini-Armstrong; Karl Pfeifer
Journal:  J Clin Invest       Date:  2006-08-24       Impact factor: 14.808

6.  Structural factors that determine the ability of adenosine and related compounds to activate the cardiac ryanodine receptor.

Authors:  W M Chan; W Welch; R Sitsapesan
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

7.  Ca2+ stores regulate ryanodine receptor Ca2+ release channels via luminal and cytosolic Ca2+ sites.

Authors:  Derek R Laver
Journal:  Biophys J       Date:  2007-03-09       Impact factor: 4.033

Review 8.  Light at the end of the Ca(2+)-release channel tunnel: structures and mechanisms involved in ion translocation in ryanodine receptor channels.

Authors:  A J Williams; D J West; R Sitsapesan
Journal:  Q Rev Biophys       Date:  2001-02       Impact factor: 5.318

9.  Regulation of the gating of the sheep cardiac sarcoplasmic reticulum Ca(2+)-release channel by luminal Ca2+.

Authors:  R Sitsapesan; A J Williams
Journal:  J Membr Biol       Date:  1994-02       Impact factor: 1.843

10.  Sheep cardiac sarcoplasmic reticulum calcium-release channels: modification of conductance and gating by temperature.

Authors:  R Sitsapesan; R A Montgomery; K T MacLeod; A J Williams
Journal:  J Physiol       Date:  1991-03       Impact factor: 5.182

View more
  8 in total

1.  Ca²+-dependent phosphorylation of RyR2 can uncouple channel gating from direct cytosolic Ca²+ regulation.

Authors:  Simon Carter; Samantha J Pitt; John Colyer; Rebecca Sitsapesan
Journal:  J Membr Biol       Date:  2011-01-28       Impact factor: 1.843

Review 2.  FK506-binding proteins 12 and 12.6 (FKBPs) as regulators of cardiac Ryanodine Receptors: Insights from new functional and structural knowledge.

Authors:  Luis A Gonano; Peter P Jones
Journal:  Channels (Austin)       Date:  2017-06-21       Impact factor: 2.581

3.  A mechanistic description of gating of the human cardiac ryanodine receptor in a regulated minimal environment.

Authors:  Saptarshi Mukherjee; N Lowri Thomas; Alan J Williams
Journal:  J Gen Physiol       Date:  2012-07-16       Impact factor: 4.086

4.  FKBP12 activates the cardiac ryanodine receptor Ca2+-release channel and is antagonised by FKBP12.6.

Authors:  Elena Galfré; Samantha J Pitt; Elisa Venturi; Mano Sitsapesan; Nathan R Zaccai; Krasimira Tsaneva-Atanasova; Stephen O'Neill; Rebecca Sitsapesan
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

5.  Selective inhibitors of cardiac ADPR cyclase as novel anti-arrhythmic compounds.

Authors:  Aimo Kannt; Kerstin Sicka; Katja Kroll; Dieter Kadereit; Heinz Gögelein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-04-19       Impact factor: 3.000

6.  Intracellular Zinc Modulates Cardiac Ryanodine Receptor-mediated Calcium Release.

Authors:  Jason Woodier; Richard D Rainbow; Alan J Stewart; Samantha J Pitt
Journal:  J Biol Chem       Date:  2015-06-03       Impact factor: 5.157

7.  Insights into the gating mechanism of the ryanodine-modified human cardiac Ca2+-release channel (ryanodine receptor 2).

Authors:  Saptarshi Mukherjee; N Lowri Thomas; Alan J Williams
Journal:  Mol Pharmacol       Date:  2014-07-07       Impact factor: 4.436

8.  FKBP12.6 activates RyR1: investigating the amino acid residues critical for channel modulation.

Authors:  Elisa Venturi; Elena Galfré; Fiona O'Brien; Samantha J Pitt; Stuart Bellamy; Richard B Sessions; Rebecca Sitsapesan
Journal:  Biophys J       Date:  2014-02-18       Impact factor: 4.033

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.